Ridgetech
Ridgetech's revenue rose 10.2% to $132 million in fiscal 2026. Its operating margin was −1.4%, down from −0.9% a year earlier. Free cash flow was −$1 million, against $1 million a year earlier. The diluted share count rose 96.6%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity.
Income statement
Ridgetech lost money in fiscal 2026: a net loss of $1 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 18 | 19 | 2 | 13 | 18 |
| Debt incl. finance leases | — | — | — | — | — |
| Net debt (negative means net cash) | — | — | — | — | — |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | — | — | — | — |
| Interest coverage | −10.3x | −416.8x | 3.0x | −11.2x | −27.8x |
| Current ratio | 1.0x | 1.0x | 0.9x | 1.7x | 2.3x |
| Quick ratio | 0.8x | 0.7x | 0.8x | 1.4x | 2.0x |
Cash flow
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY24 | FY25 | FY26 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | 0.3% | −2.3% | 9.1% |
| Altman Z'' | −2.62 | 0.16 | 1.77 |
| Accruals ratio | −1.2% | 11.2% | 0.2% |
The nine F-score tests
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Fail | Pass | Fail |
| Cash from operations is positive | Fail | Pass | Fail |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Pass | Fail | Fail |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | Fail | Pass | Pass |
| Share count didn't rise | Pass | Fail | Fail |
| Gross margin rose | Pass | Fail | Pass |
| Revenue rose relative to assets | Pass | Fail | Pass |
| F-score | — | — | — |
Compare
Put Ridgetech side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Ridgetech | FY26 | 10.2% | −1.4% | −1.1% | — | — | — | |
| Grail | FY25 | 17.2% | −382.0% | −203.8% | — | — | — | Compare |
| AirSculpt Technologies | FY25 | −15.8% | −7.6% | 0.5% | −6.6% | 39.0x | 3 | Compare |
| MDxHealth | FY25 | 19.8% | −13.4% | −3.1% | −41.8% | — | 3 | Compare |
| SBC Medical Group | FY25 | −15.5% | 38.9% | 13.4% | 38.4% | −1.7x | 4 | Compare |
7 years of figures
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 117 | 133 | 164 | 120 | 124 | 120 | 132 |
| Revenue growth | — | 13.5% | 23.5% | −26.9% | 3.2% | −3.2% | 10.2% |
| Gross profit | 26 | 29 | 36 | 4 | 5 | 4 | 5 |
| Research and development | — | — | — | — | — | — | — |
| Operating income | −7 | −9 | −3 | −13 | 1 | −1 | −2 |
| Net income | −6 | −8 | −3 | −21 | −4 | 10 | −1 |
| Diluted EPS (US$) | −43.20 | −47.80 | −18.35 | −41.46 | −439.78 | 275.87 | −17.21 |
| Diluted shares (millions) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow | |||||||
| Cash from operations | −7 | −0 | −5 | −3 | −3 | 1 | −1 |
| Capital expenditure | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −8 | −0 | −5 | −3 | −3 | 1 | −1 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 5 | 0 |
| Stock-based compensation | 0 | 4 | — | 10 | — | — | — |
| Balance sheet at fiscal year end | |||||||
| Cash and short-term investments | 31 | 22 | 18 | 19 | 2 | 13 | 18 |
| Debt incl. finance leases | — | 28 | — | — | — | — | — |
| Total assets | — | 106 | 106 | 91 | 95 | 64 | 69 |
| Total liabilities | — | 82 | 84 | 74 | 81 | 35 | 28 |
| Shareholders' equity | 19 | 26 | 24 | 18 | 16 | 30 | 41 |
| Margins and ratios | |||||||
| Gross margin | 21.8% | 22.0% | 22.2% | 3.0% | 3.9% | 3.2% | 3.6% |
| Operating margin | −6.0% | −6.6% | −1.6% | −10.9% | 0.5% | −0.9% | −1.4% |
| Net margin | −5.0% | −6.1% | −1.9% | −17.6% | −3.4% | 8.5% | −0.9% |
| Free cash flow margin | −6.5% | −0.1% | −3.3% | −2.8% | −2.8% | 0.9% | −1.1% |
| Rule of 40 (growth + FCF margin) | — | 13.3% | 20.1% | −29.7% | 0.3% | −2.3% | 9.1% |
| Return on capital | — | — | — | — | — | — | — |
| Return on equity | — | — | −12.8% | −100.4% | −25.2% | 45.0% | −3.5% |
| Return on assets | — | — | −3.0% | −21.4% | −4.5% | 12.8% | −1.9% |
| Net debt to EBITDA | — | — | — | — | — | — | — |